Authors:
McMahon, D
Lederman, M
Haas, DW
Haubrich, R
Stanford, J
Cooney, E
Horton, J
Kelleher, D
Ross, L
Cutrell, A
Lee, D
Spreen, W
Mellors, JW
Citation: D. Mcmahon et al., Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adults, ANTIVIR TH, 6(2), 2001, pp. 105-114
Authors:
Lederman, MM
McKinnis, R
Kelleher, D
Cutrell, A
Mellors, J
Neisler, M
Cooney, E
Haas, DW
Haubrich, R
Stanford, J
Horton, J
Landay, A
Spreen, W
Citation: Mm. Lederman et al., Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase, AIDS, 14(17), 2000, pp. 2635-2642
Authors:
Schooley, RT
Spino, C
Kuritzkes, D
Walker, BD
Valentine, FT
Hirsch, MS
Cooney, E
Friedland, G
Kundu, S
Merigan, TC
McElrath, MJ
Collier, A
Plaeger, S
Mitsuyasu, R
Kahn, J
Haslett, P
Uherova, P
deGruttola, V
Chiu, S
Zhang, B
Jones, G
Bell, D
Ketter, N
Twadell, T
Chernoff, D
Rosandich, M
Citation: Rt. Schooley et al., Two double-blinded, randomized, comparative trials of 4 human immunodeficiency virus type 1 (HIV-1) envelope vaccines in HIV-1-infected individuals across a spectrum of disease severity: AIDS clinical trials groups 209 and 214, J INFEC DIS, 182(5), 2000, pp. 1357-1364